RIGL Rigel Pharmaceuticals, Inc. - Common Stock

NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗
$45,00
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 4, 2026

RIGL Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$45.00
Marktkapitalisierung
$824M
P/E (TTM)
2.3
EPS (TTM)
$19.48
Umsatz (TTM)
$294M
Dividendenrendite
ROE
155.1%
Verschuldungsgrad
52W-Spanne
$25 – $52

RIGL Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $294M
10-point trend, +1343.8%
2016-12-31 2025-12-31
EPS $19.48
7-point trend, +4970.0%
2019-12-31 2025-12-31
Freier Cashflow
6-point trend, +3.2%
2016-12-31 2022-12-31
Margen 124.7%

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
RIGL
Peer-Median
P/E (TTM)
5-point trend, +100.9%
2.3
68.0
P/S (TTM) (K/V (TTM))
5-point trend, -91.3%
2.8
20.6
P/B (K/B)
5-point trend, -98.7%
2.1
3.2

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
RIGL
Peer-Median
Operating Margin (Betriebsgewinnmarge)
5-point trend, +609.3%
42.6%
Net Profit Margin (Nettogewinnmarge)
5-point trend, +1139.3%
124.7%
-94.7%
ROA
5-point trend, +939.8%
108.3%
-25.6%
ROE
5-point trend, +446.4%
155.1%
-30.9%
ROIC
3-point trend, +326.7%
96.5%

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
RIGL
Peer-Median
Current Ratio (Liquiditätsgrad)
5-point trend, -0.4%
2.4
9.3
Quick Ratio
5-point trend, -5.7%
2.1

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
RIGL
Peer-Median
Revenue YoY (Umsatz YoY)
5-point trend, +97.2%
64.1%
Revenue CAGR 3Y (Umsatz CAGR 3J)
5-point trend, +97.2%
34.8%
Revenue CAGR 5Y (Umsatz CAGR 5J)
5-point trend, +97.2%
22.1%
EPS YoY (EPS VjV)
5-point trend, +17809.1%
1867.7%
Net Income YoY (Nettogewinn YoY)
5-point trend, +2148.8%
1999.1%

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
RIGL
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, +17809.1%
$19.48

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
RIGL
Peer-Median

RIGL Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 11 Analysten
  • Starker Kauf 4 36,4%
  • Kauf 4 36,4%
  • Halten 3 27,3%
  • Verkauf 0 0,0%
  • Starker Verkauf 0 0,0%

12-Monats-Kursziel

5 Analysten · 2026-08-17
Median-Ziel $55.00 +22,2%
Mittelwert-Ziel $61.20 +36,0%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
0.26%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $0.88 $0.63 0.25%
31. März 2026 $0.44 $0.78 -0.34%
31. Dezember 2025 $1.15 $1.27 -0.12%
30. September 2025 $1.46 $0.87 0.59%
30. Juni 2025 $3.28 $2.63 0.65%
31. März 2025 $0.63 $0.09 0.54%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
RIGL $784M 2.2 64.1% 124.7% 155.1%
FTH
IMMX $277M -5.9 -59.8%
AURA $347M -3.1 -29.7% -1601.4% -68.2%
MNPR
ACHV -4.0
CTMX $725M -44.8% -22.8% -15.9%
RGNX $733M -3.8 104.5% -113.8% -122.5%
NGNE $319M -4.9 -33.6%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 16
Jährliche Gewinn- und Verlustrechnung-Daten für RIGL
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue 10-point trend, +1343.8% $294M $179M $117M $120M $149M $109M $59M $45M $4M $20M
Cost of Revenue 8-point trend, +6736.6% $20M $19M $7M $2M $1M $895.0K $906.0K $287.0K · ·
R&D Expense 3-point trend, +35.8% $33M $23M $25M · · · · · · ·
SG&A Expense 10-point trend, +454.3% $116M $113M $106M $112M $92M $77M $75M $70M $38M $21M
Operating Expenses 10-point trend, +87.3% $169M $155M $137M $176M $162M $138M $128M $117M $84M $90M
Operating Income 10-point trend, +279.9% $125M $24M $-20M $-56M $-12M $-29M $-69M $-73M $-80M $-70M
Interest Expense 6-point trend, +2263.6% · $8M $7M $4M $5M $1M $335.0K · · ·
Interest Income 10-point trend, +742.3% $4M $2M $2M $684.0K $47.0K $582.0K $3M $2M $892.0K $437.0K
Pretax Income 7-point trend, +282.1% $122M $18M $-25M $-59M $-17M $-30M $-67M · · ·
Income Tax 7-point trend, -245197000.00 $-245M $881.0K $0 · $605.0K · · $0 $0 $0
Net Income 10-point trend, +630.3% $367M $17M $-25M $-59M $-18M $-30M $-67M $-70M $-78M $-69M
EPS (Basic) 7-point trend, +5200.0% $20.40 $0.99 $-1.44 $-3.44 $-0.11 $-0.18 $-0.40 · · ·
EPS (Diluted) 7-point trend, +4970.0% $19.48 $0.99 $-1.44 $-3.44 $-0.11 $-0.18 $-0.40 · · ·
Shares (Basic) 7-point trend, -89.3% 17,987,000 17,579,000 17,401,000 17,049,000 170,492,000 168,754,000 167,400,000 · · ·
Shares (Diluted) 7-point trend, -88.7% 18,840,000 17,687,000 17,401,000 17,049,000 170,492,000 168,754,000 167,400,000 · · ·
EBITDA 9-point trend, +285.9% $128M $26M $-19M $-55M $-11M $-28M $-68M $-72M · $-69M
Bilanz 26
Jährliche Bilanz-Daten für RIGL
Kennzahl Trend 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +130.1% $41M $57M $33M $24M $19M $30M $23M $76M $38M $18M
Short-term Investments 10-point trend, +100.2% $114M $21M $24M $34M $106M $27M $76M $52M $77M $57M
Receivables 10-point trend, +51763000.00 $52M $42M $31M $40M $15M $16M $10M $4M $0 $0
Inventory 8-point trend, +1187.0% $12M $6M $6M $9M $7M $2M $1M $894.0K · ·
Prepaid Expense 10-point trend, +1415.3% $22M $10M $6M $8M $7M $14M $9M $3M $2M $1M
Other Current Assets 2-point trend, +15.1% $5M $5M · · · · · · · ·
Current Assets 10-point trend, +215.1% $240M $135M $99M $116M $154M $89M $119M $137M $117M $76M
PP&E (Net) 10-point trend, -97.4% $30.0K $92.0K $165.0K $857.0K $2M $3M $2M $1M $875.0K $1M
PP&E (Gross) 10-point trend, -98.3% $347.0K $353.0K $2M $12M $17M $16M $15M $14M $13M $20M
Accum. Depreciation 10-point trend, -98.3% $317.0K $261.0K $2M $11M $15M $14M $13M $13M $12M $19M
Intangibles 4-point trend, +65.5% $25M $27M $14M $15M · · · · · ·
Other Non-current Assets 10-point trend, +149.7% $2M $2M $3M $640.0K $974.0K $824.0K $696.0K $735.0K $803.0K $764.0K
Total Assets 10-point trend, +557.3% $514M $164M $117M $134M $167M $110M $148M $139M $119M $78M
Accounts Payable 10-point trend, +29.3% $7M $3M $7M $23M $4M $4M $4M $6M $3M $6M
Accrued Liabilities 3-point trend, +26.2% · · · · $4M $4M $3M · · ·
Current Liabilities 10-point trend, +339.3% $99M $63M $53M $65M $64M $41M $58M $28M $18M $23M
Capital Leases 7-point trend, -97.9% $395.0K $0 $285.0K $972.0K $759.0K $11M $19M · · ·
Other Non-current Liabilities 9-point trend, -100.0% $0 $40M $40M $42M $53M $5M $5M · $38.0K $2.0K
Total Liabilities 5-point trend, -10.8% $122M $161M $146M $148M $137M · · · · ·
Long-term Debt 7-point trend, +425.0% $52M $60M $60M $40M $20M $20M $10M · · ·
Common Stock 10-point trend, -82.0% $18.0K $18.0K $17.0K $174.0K $172.0K $169.0K $168.0K $167.0K $147.0K $100.0K
Retained Earnings 10-point trend, +3.6% $-1.02B $-1.39B $-1.41B $-1.38B $-1.32B $-1.31B $-1.28B $-1.21B $-1.14B $-1.06B
AOCI 10-point trend, +1105.6% $181.0K $10.0K $8.0K $-153.0K $-102.0K $-4.0K $23.0K $-24.0K $-82.0K $-18.0K
Stockholders' Equity 10-point trend, +611.4% $391M $3M $-29M $-14M $30M $34M $54M $110M $101M $55M
Liabilities + Equity 10-point trend, +557.3% $514M $164M $117M $134M $167M $110M $148M $139M $119M $78M
Shares Outstanding 10-point trend, -81.6% 18,310,934 17,710,216 17,482,513 173,398,645 171,602,226 169,316,782 167,987,850 167,171,505 146,814,906 99,269,418
Cashflow 16
Jährliche Cashflow-Daten für RIGL
Kennzahl Trend 2025202420232022202120202019201820172016
D&A 10-point trend, +156.6% $2M $2M $1M $998.0K $1M $706.0K $683.0K $594.0K $465.0K $941.0K
Stock-based Comp 10-point trend, +73.3% $13M $12M $9M $12M $9M $7M $9M $8M $6M $7M
Deferred Tax 3-point trend, -245852000.00 $-246M $0 $0 · · · · · · ·
Amort. of Intangibles 4-point trend, +2300.0% $2M $2M $1M $100.0K · · · · · ·
Restructuring 3-point trend, -77.1% · · · $1M $4M · · · · $6M
Other Non-cash 8-point trend, -1907.0% $-61M $-635.0K $9M $-29M $13M $-30M $16M $3M · ·
Operating Cash Flow 10-point trend, +199.7% $76M $31M $-6M $-74M $6M $-52M $-42M $-59M $-78M $-76M
CapEx 7-point trend, -44.0% · · · $450.0K $627.0K $1M $1M $1M $164.0K $804.0K
Investing Cash Flow 10-point trend, -471.2% $-92M $4M $-4M $73M $-80M $47M $-24M $25M $-19M $25M
Stock Issued 3-point trend, +184.8% · · · · · · · $67M $114M $24M
Net Stock Activity 2-point trend, +123.9% · · · · · · · $67M · $30M
Financing Cash Flow 10-point trend, -97.6% $601.0K $-12M $18M $7M $63M $13M $11M $72M $118M $25M
Net Change in Cash 3-point trend, +247.3% · · · · · · · $38M $21M $-26M
Taxes Paid 3-point trend, +1212.3% $1M $331.0K $81.0K · · · · · · ·
Free Cash Flow 6-point trend, +3.2% · · · $-74M $5M $-53M $-43M $-60M · $-77M
Levered FCF · · · · $221.1K · · · · ·
Rentabilität 7
Jährliche Rentabilität-Daten für RIGL
Kennzahl Trend 2025202420232022202120202019201820172016
Operating Margin 8-point trend, +126.1% 42.6% 13.5% -17.5% -46.2% -8.4% -26.7% -116.5% -163.3% · ·
Net Margin 8-point trend, +178.8% 124.7% 9.8% -21.5% -48.7% -12.0% -27.4% -112.8% -158.3% · ·
Pretax Margin 5-point trend, +456.9% 41.4% 10.2% -21.5% -48.7% -11.6% · · · · ·
EBITDA Margin 8-point trend, +126.8% 43.5% 14.7% -16.5% -45.4% -7.6% -26.0% -115.4% -162.0% · ·
ROA 8-point trend, +298.5% 108.3% 12.4% -20.0% -38.8% -12.9% -23.1% -46.7% -54.6% · ·
ROE 8-point trend, +334.7% 155.1% -308.2% 83.0% 350.2% -44.8% -70.0% -109.0% -66.1% · ·
ROIC 3-point trend, +326.7% 96.5% 700.5% · · -42.6% · · · · ·
Liquidität & Solvenz 3
Jährliche Liquidität & Solvenz-Daten für RIGL
Kennzahl Trend 2025202420232022202120202019201820172016
Current Ratio 9-point trend, -28.3% 2.4 2.1 1.9 1.8 2.4 2.2 2.0 4.9 · 3.4
Quick Ratio 9-point trend, -37.1% 2.1 1.9 1.6 1.5 2.2 1.8 1.9 4.8 · 3.3
Interest Coverage 6-point trend, +101.5% · 3.1 -3.0 -15.0 -2.6 -21.4 -206.2 · · ·
Effizienz 3
Jährliche Effizienz-Daten für RIGL
Kennzahl Trend 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +152.0% 0.9 1.3 0.9 0.8 1.1 0.8 0.4 0.3 · ·
Inventory Turnover 8-point trend, +249.1% 2.2 3.2 1.0 0.2 0.3 0.6 0.8 0.6 · ·
Receivables Turnover 8-point trend, -71.1% 6.3 5.0 3.3 4.3 9.5 8.3 8.4 21.8 · ·
Pro Aktie 5
Jährliche Pro Aktie-Daten für RIGL
Kennzahl Trend 2025202420232022202120202019201820172016
Book Value / Share 9-point trend, +3757.0% $21.38 $0.19 $-0.16 $-0.08 $0.18 $0.20 $0.32 $0.66 · $0.55
Revenue / Share 5-point trend, +1684.5% $15.62 $10.14 $0.67 $0.70 $0.88 · · · · ·
Cash Flow / Share 5-point trend, +11539.7% $4.02 $1.78 $-0.03 $-0.43 $0.03 · · · · ·
Cash / Share 9-point trend, +1147.9% $2.22 $3.20 $0.19 $0.14 $0.11 $0.18 $0.13 $0.46 · $0.18
EPS (TTM) 7-point trend, +4970.0% $19.48 $0.99 $-1.44 $-3.44 $-0.11 $-0.18 $-0.40 · · ·
Wachstumsraten 5
Jährliche Wachstumsraten-Daten für RIGL
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, +71.6% 64.1% 53.4% -2.8% -19.4% 37.4% · · · · ·
Revenue CAGR 3Y 3-point trend, +1307.3% 34.8% 6.3% 2.5% · · · · · · ·
Revenue CAGR 5Y 22.1% · · · · · · · · ·
EPS YoY 1867.7% · · · · · · · · ·
Net Income YoY 1999.1% · · · · · · · · ·
Bewertung (TTM) 10
Jährliche Bewertung (TTM)-Daten für RIGL
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, +1343.8% $294M $179M $117M $120M $149M $109M $59M $45M $4M $20M
Net Income TTM 10-point trend, +630.3% $367M $17M $-25M $-59M $-18M $-30M $-67M $-70M $-78M $-69M
Market Cap 9-point trend, -66.8% $784M $298M $2.53B $2.60B $4.55B $5.93B $3.59B $3.84B · $2.36B
P/E 7-point trend, +104.1% 2.2 17.0 -10.1 -4.4 -240.9 -194.4 -53.5 · · ·
P/S 9-point trend, -97.7% 2.7 1.7 21.7 21.6 30.5 54.6 60.6 86.4 · 115.9
P/B 9-point trend, -95.3% 2.0 90.6 -88.5 -191.0 149.7 174.2 66.8 35.0 · 42.9
P / Tangible Book 3-point trend, -98.8% 2.1 · · · 149.7 174.2 · · · ·
P / Cash Flow 9-point trend, +133.3% 10.4 9.5 -441.4 -35.3 773.6 -113.6 -86.6 -65.4 · -31.1
P / FCF 6-point trend, -13.8% · · · -35.0 866.0 -110.9 -83.7 -64.2 · -30.8
Earnings Yield 7-point trend, +2532.1% 45.5% 5.9% -9.9% -22.9% -0.42% -0.51% -1.9% · · ·

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $294M$179M$117M$120M$149M
Betriebsgewinnmarge % 42.6%13.5%-17.5%-46.2%-8.4%
Nettoergebnis $367M$17M$-25M$-59M$-18M
Verwässerte EPS $19.48$0.99$-1.44$-3.44$-0.11
Bilanz
2025-12-312024-12-312023-12-312022-12-312021-12-31
Liquiditätsgrad 2.42.11.91.82.4
Quick Ratio 2.11.91.61.52.2
Cashflow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Freier Cashflow $-74M$5M

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 170 Einreicher · $451.1M gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
37 (+25 vs. Vorquartal) 22 (-22 vs. Vorquartal) 43 (-25 vs. Vorquartal) 59 (+12 vs. Vorquartal) +1.6M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
Soleus Capital Management, L.P. $72.117.876 1.843.504 15,99% Aktien
ARMISTICE CAPITAL, LLC $65.408.640 1.672.000 14,50% Aktien
STATE STREET CORP $40.684.565 1.039.994 9,02% Aktien
VANGUARD CAPITAL MANAGEMENT LLC $30.713.386 785.107 6,81% Aktien
AMERICAN CENTURY COMPANIES INC $29.016.008 741.718 6,43% Aktien
GEODE CAPITAL MANAGEMENT, LLC $16.233.871 414.860 3,60% Aktien
CM Management, LLC $9.780.000 250.000 2,17% Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC $9.143.439 233.728 2,03% Aktien
D. E. Shaw & Co., Inc. $8.343.357 213.276 1,85% Aktien
DIMENSIONAL FUND ADVISORS LP $8.288.120 211.864 1,84% Aktien
TWO SIGMA INVESTMENTS, LP $8.120.451 207.578 1,80% Aktien
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $7.628.000 195.000 1,69% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $6.049.008 154.627 1,34% Aktien
RENAISSANCE TECHNOLOGIES LLC $5.705.496 145.846 1,26% Aktien
GOLDMAN SACHS GROUP INC $5.507.079 140.774 1,22% Aktien
VANGUARD GROUP INC $5.228.301 122.071 1,16% Aktien
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $5.131.644 131.177 1,14% Aktien
AQR CAPITAL MANAGEMENT LLC $4.875.134 124.620 1,08% Aktien
BRIDGEWAY CAPITAL MANAGEMENT, LLC $4.858.078 124.184 1,08% Aktien
VANGUARD FIDUCIARY TRUST CO $4.762.195 121.733 1,06% Aktien
BANK OF AMERICA CORP /DE/ $4.448.962 113.726 0,99% Aktien
GLOBEFLEX CAPITAL L P $4.407.729 112.672 0,98% Aktien
CenterBook Partners LP $4.286.574 109.575 0,95% Aktien
FMR LLC $3.759.432 96.100 0,83% Aktien
RITHOLTZ WEALTH MANAGEMENT $3.694.884 94.450 0,82% Aktien
JANUS HENDERSON GROUP PLC $3.674.114 135.877 0,81% Aktien
MILLENNIUM MANAGEMENT LLC $3.665.114 93.689 0,81% Aktien
FIRST TRUST ADVISORS LP $3.182.099 81.342 0,71% Aktien
Empowered Funds, LLC $3.097.678 79.184 0,69% Aktien
Brandywine Global Investment Management, LLC $3.065.343 71.570 0,68% Aktien
FRANKLIN RESOURCES INC $2.831.114 72.370 0,63% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $2.687.544 68.700 0,60% Kaufoption
Squarepoint Ops LLC $2.607.661 66.658 0,58% Aktien
BlackRock, Inc. $2.389.410 61.079 0,53% Aktien
BURNEY CO/ $2.181.683 55.769 0,48% Aktien
Universal- Beteiligungs- und Servicegesellschaft mbH $2.159.424 55.200 0,48% Aktien
OMERS ADMINISTRATION Corp $2.030.328 51.900 0,45% Aktien
PRINCIPAL FINANCIAL GROUP INC $2.017.066 51.561 0,45% Aktien
Woodline Partners LP $1.956.000 50.000 0,43% Aktien
Connor, Clark & Lunn Investment Management Ltd. $1.920.636 49.096 0,43% Aktien
SEGALL BRYANT & HAMILL, LLC $1.794.747 45.878 0,40% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1.635.216 41.800 0,36% Verkaufsoption
WELLS FARGO & COMPANY/MN $1.528.927 39.083 0,34% Aktien
ALPS ADVISORS INC $1.488.633 38.053 0,33% Aktien
Bank of New York Mellon Corp $1.393.963 35.633 0,31% Aktien
Virtus Investment Advisers, LLC $1.384.848 35.400 0,31% Aktien
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $1.370.334 35.029 0,30% Aktien
Trexquant Investment LP $1.312.945 33.562 0,29% Aktien
SIERRA SUMMIT ADVISORS LLC $1.246.990 31.876 0,28% Aktien
CITIGROUP INC $1.232.436 31.504 0,27% Aktien
CREDIT AGRICOLE S A $1.126.656 28.800 0,25% Aktien
RHUMBLINE ADVISERS $1.016.483 25.984 0,23% Aktien
CITADEL ADVISORS LLC $962.352 24.600 0,21% Kaufoption
Vanguard Global Advisers, LLC $949.247 24.265 0,21% Aktien
Engineers Gate Manager LP $933.638 23.866 0,21% Aktien
AXA Investment Managers S.A. $923.388 32.594 0,20% Aktien
DIADEMA PARTNERS LP $892.562 22.816 0,20% Aktien
ALLIANCEBERNSTEIN L.P. $866.172 32.033 0,19% Aktien
MARSHALL WACE, LLP $863.770 22.080 0,19% Aktien
STATE OF WISCONSIN INVESTMENT BOARD $847.730 21.670 0,19% Aktien
STRS OHIO $813.696 20.800 0,18% Aktien
Man Group plc $813.540 20.796 0,18% Aktien
Quantinno Capital Management LP $802.116 20.504 0,18% Aktien
HSBC HOLDINGS PLC $744.752 18.577 0,17% Aktien
CANADA PENSION PLAN INVESTMENT BOARD $735.456 18.800 0,16% Aktien
Rafferty Asset Management, LLC $707.094 18.075 0,16% Aktien
DEUTSCHE BANK AG\ $702.478 17.957 0,16% Aktien
MACKENZIE FINANCIAL CORP $701.109 17.922 0,16% Aktien
TWO SIGMA ADVISERS, LP $693.760 16.198 0,15% Aktien
Aquatic Capital Management LLC $674.155 17.233 0,15% Aktien
CITADEL ADVISORS LLC $668.952 17.100 0,15% Verkaufsoption
WELLINGTON MANAGEMENT GROUP LLP $632.062 16.157 0,14% Aktien
BOKF, NA $598.771 15.306 0,13% Aktien
NJ State Employees Deferred Compensation Plan $566.600 20.000 0,13% Aktien
Pale Fire Capital SE $557.538 14.252 0,12% Aktien
AVIVA PLC $529.607 13.538 0,12% Aktien
BARCLAYS PLC $524.091 13.397 0,12% Aktien
Graham Capital Management, L.P. $471.396 12.050 0,10% Aktien
MetLife Investment Management, LLC $447.063 11.428 0,10% Aktien
OSAIC HOLDINGS, INC. $436.075 11.151 0,10% Aktien
Nuveen Asset Management, LLC $387.751 23.053 0,09% Aktien
WOLVERINE TRADING, LLC $376.625 13.100 0,08% Kaufoption
PROFUND ADVISORS LLC $358.887 9.174 0,08% Aktien
PRUDENTIAL FINANCIAL INC $337.527 8.628 0,07% Aktien
Advantage Alpha Capital Partners LP $334.407 11.804 0,07% Aktien
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $296.099 7.569 0,07% Aktien
JANE STREET GROUP, LLC $285.576 7.300 0,06% Kaufoption
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $280.177 7.162 0,06% Aktien
Invesco Ltd. $277.126 7.084 0,06% Aktien
NEW YORK STATE COMMON RETIREMENT FUND $275.248 7.036 0,06% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $243.053 6.213 0,05% Aktien
Caprock Group, LLC $238.828 6.105 0,05% Aktien
Jump Financial, LLC $238.632 6.100 0,05% Aktien
Persistent Asset Partners Ltd $227.718 5.821 0,05% Aktien
Police & Firemen's Retirement System of New Jersey $227.600 5.818 0,05% Aktien
Nuveen, LLC $226.231 5.783 0,05% Aktien
Russell Investments Group, Ltd. $210.504 5.381 0,05% Aktien
BNP PARIBAS FINANCIAL MARKETS $133.908 3.423 0,03% Aktien
MORGAN STANLEY $131.678 3.366 0,03% Aktien
AlphaQuest LLC $127.462 2.976 0,03% Aktien

Unternehmensinsider 41 Insider · 19 Führungskräfte · 21 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Raul R Rodriguez CEO, President 17. Juni 2026 A 279.593 0 0 $0
James M Gower CEO & Board Chairman 27. Februar 2014 A 180.676 0 0 $0
Dean L Schorno EVP & Chief Financial Officer 17. Juni 2026 A 78.790 0 0 $0
Ryan D Maynard EVP & CFO 3. November 2017 M 0 0 0 $0
James H Welch CFO, VP & Secretary 25. Januar 2006 A 3.757 0 0 $0
Lisa Rojkjaer EVP, Chief Medical Officer 17. Juni 2026 A 34.003 0 0 $0
David A Santos EVP, Chief Commercial Officer 17. Juni 2026 A 61.996 0 0 $0
Raymond J. Furey EVP, GC, CCO & Corp Sec 17. Juni 2026 A 50.936 0 0 $0
Wolfgang Dummer EVP & CMO 2. Februar 2023 S 72.459 0 0 $0
Dolly Vance EVP Corp. Affairs, G.C., Sect. 14. September 2022 A 575 0 0 $0
Nelson Cabatuan VP,Finance & Princ.Acctg. Off. 14. Mai 2020 A 58 0 0 $0
Eldon C. Mayer III EVP & Chief Commercial Officer 18. November 2019 A 215.000 0 0 $0
Joseph Lasaga Sr.VP Bus.Dev.Alliance Mgmt. 18. November 2019 A 0 0 $0
Esteban Masuda Sr. VP Research 18. November 2019 S 0 0 $0
Stacy Markel EVP Human Resources 20. März 2019 A 0 0 $0
Anne-Marie Duliege EVP & Chief Medical Officer 20. März 2019 A 0 0 0 $0
Donald G Payan EVP, Pres. Discovery&Research 30. August 2016 S 53.031 0 0 $0
Elliot B Grossbard EVP, CMO 26. Januar 2016 A 2.000 0 0 $0
Robin D G Cooper Sr. V.P. Pharmaceutical Scs. 31. Januar 2008 A 9.000 0 0 $0
Kamil Ali-Jackson Direktor 22. Juni 2026 S 10.125 0 2 $-160.425
Alison L. Hannah Direktor 15. Mai 2026 A 16.375 0 0 $0
Mark W Frohlich Direktor 15. Mai 2026 A 7.000 0 0 $0
Jane Wasman Direktor 15. Mai 2026 A 18.250 0 0 $0
Anthony Gregg Lapointe Direktor 15. Mai 2026 A 18.250 0 0 $0
MILLER MICHAEL PATRICK Direktor 15. Mai 2026 A 5.937 0 0 $0
Walter H Moos Direktor 15. Mai 2026 A 18.472 0 1 $-145.440
Brian L. Kotzin Direktor 25. Mai 2024 A 100.000 0 0 $0
LYONS GARY A Direktor 26. Mai 2023 A 75.000 0 0 $0
Keith Katkin Direktor 19. Mai 2021 A 25.000 0 0 $0
Bradford S Goodwin Direktor 19. Mai 2021 A 35.000 0 0 $0
Peter S Ringrose Direktor 17. Mai 2018 A 0 0 $0
SHERWIN STEPHEN A Direktor 11. Mai 2016 A 0 0 $0
Hollings Renton Direktor 15. Mai 2013 A 0 0 $0
Jean Deleage Direktor 28. Mai 2010 A 697 0 0 $0
Alan D Frazier Direktor 7. August 2006 A 10.905 0 0 $0
Nicholas J Simon III Direktor 3. Juni 2005 A 0 0 0 $0
Dennis Henner Direktor 5. Januar 2005 S 0 0 0 $0
Michael Steinmetz 10%-Eigentümer 2. August 2004 S 1.833.597 0 0 $0
Nicholas Galakatos 10%-Eigentümer 2. Juli 2004 S 1.833.597 0 0 $0
Luke Evnin 10%-Eigentümer 2. Juli 2004 S 1.833.597 0 0 $0
ANSBERT GADICKE 10%-Eigentümer 2. Juli 2004 J 0 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 5 Beteiligungen

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 27. Januar 2005 Erste Einreichung Passive Anlage SEC
I.R.S.Identification Nos. of above persons (entities only). FRAZIER HEALTHCARE II, L.P., I.R.S.Identification Nos. of above persons (entities only). FHM II, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER HEALTHCARE IV, L.P., I.R.S.Identification Nos. of above persons (entities only). FRAZIER AFFILIATES IV, L.P.., I.R.S.Identification Nos. of above persons (entities only). FHM IV, L.P., I.R.S.Identification Nos. of above persons (entities only). FHM IV, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER MANAGEMENT, L.L.C., I.R.S.Identification Nos. of above persons (entities only). FRAZIER & COMPANY, INC., I.R.S.Identification Nos. of above persons (entities only). ALAN D. FRAZIER 14. April 2004 Erste Einreichung Passive Anlage SEC
Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter 7. Juli 2003 Erste Einreichung Vorstandskampagne SEC
MPM BioVentures III, L.P., MPM BioVentures III-QP, L.P., MPM BioVentures III Parallel Fund, L.P., MPM BioVentures III GmbH & Co. Beteiligungs KG, MPM Asset Management Investors 2003 BVIII, LLC, MPM BioEquities Master Fund, L.P., MPM BioVentures III GP, LP, MPM BioVentures III LLC, MPM BioEquities GP, LP, MPM BioEquities GP, LLC, Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nick Simon, III, Michael Steinmetz, Kurt von Emster, Kurt Wheeler 7. Juli 2003 Erste Einreichung Vorstandskampagne SEC
MPM Bio Ventures III, L.P., MPM Bio Ventures III-QP, L.P., MPM Bio Ventures III Parallel Fund, L.P., MPM Bio Ventures III GmbH & Co. Beteiligungs KG, MPM Asset Management Investors 2003 BVIII, LLC, MPM BioEquities Master Fund, L.P., MPM Bio Ventures III GP, L.P., MPM Bio Ventures III LLC, MPM BioEquities GP, L.P., MPM BioEquities GP, LLC, Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Robert Liptak, Nicholas Simon, III, Michael Steinmetz, Kurt von Emster, Kurt Wheeler 14. Mai 2003 Erste Einreichung SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 51 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
IDNA · iShares Trust 0,77% 38.807 SH 8. August 2026 Täglich
QQQS · Invesco Exchange-Traded Fund Trust … 0,65% 3.672 SH 8. August 2026 Täglich
AFSM · First Trust Exchange-Traded Fund VI… 0,53% 17.221 NS 31. Mai 2026 N-PORT
BBC · ETFis Series Trust I 0,52% 6.766 NS 30. April 2026 N-PORT
BRNY · EA Series Trust 0,45% 86.788 NS 30. April 2026 N-PORT
SBIO · ALPS ETF Trust 0,36% 19.042 NS 31. Mai 2026 N-PORT
JSML · Janus Detroit Street Trust 0,34% 37.605 NS 30. April 2026 N-PORT
JSMD · Janus Detroit Street Trust 0,30% 102.534 NS 30. April 2026 N-PORT
BFOR · ALPS ETF Trust 0,27% 19.079 NS 31. Mai 2026 N-PORT
LABU · Direxion Shares ETF Trust 0,23% 40.551 NS 30. April 2026 N-PORT
IWC · iShares Trust 0,16% 62.571 SH 8. August 2026 Täglich
JPSE · J.P. Morgan Exchange-Traded Fund Tr… 0,15% 30.071 NS 30. April 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,13% 23.978 SH 8. August 2026 Täglich
CALF · Pacer Funds Trust 0,10% 113.280 NS 30. April 2026 N-PORT
GSSC · Goldman Sachs ETF Trust 0,07% 23.773 NS 31. Mai 2026 N-PORT
AVUV · AMERICAN CENTURY ETF TRUST 0,07% 594.889 NS 31. Mai 2026 N-PORT
IBB · iShares Trust 0,05% 132.606 SH 8. August 2026 Täglich
IBBQ · Invesco Exchange-Traded Fund Trust … 0,05% 1.005 SH 8. August 2026 Täglich
VFMO · VANGUARD WELLINGTON FUND 0,05% 27.549 SH 8. August 2026 Täglich
VTWV · VANGUARD SCOTTSDALE FUNDS 0,05% 15.998 SH 8. August 2026 Täglich
IWN · iShares Trust 0,05% 170.765 SH 8. August 2026 Täglich
BIB · ProShares Trust 0,03% 672 NS 31. Mai 2026 N-PORT
IWM · iShares Trust 0,02% 472.222 SH 8. August 2026 Täglich
AVSC · AMERICAN CENTURY ETF TRUST 0,02% 20.787 NS 31. Mai 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,02% 14.496 SH 8. August 2026 Täglich
VTWO · VANGUARD SCOTTSDALE FUNDS 0,02% 105.855 SH 8. August 2026 Täglich
RSSL · Global X Funds 0,02% 7.831 NS 30. April 2026 N-PORT
TECB · iShares Trust 0,02% 1.868 SH 8. August 2026 Täglich
ITWO · ProShares Trust 0,01% 843 NS 31. Mai 2026 N-PORT
DFAS · Dimensional ETF Trust 0,01% 58.389 NS 30. April 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,01% 89.359 NS 31. Mai 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,01% 212.359 SH 8. August 2026 Täglich
VHT · VANGUARD WORLD FUND 0,01% 54.159 SH 8. August 2026 Täglich
OMFS · Invesco Exchange-Traded Self-Indexe… 0,01% 622 SH 8. August 2026 Täglich
UWM · ProShares Trust 0,01% 659 NS 31. Mai 2026 N-PORT
AVSU · AMERICAN CENTURY ETF TRUST 0,01% 1.135 NS 31. Mai 2026 N-PORT
URTY · ProShares Trust 0,01% 665 NS 31. Mai 2026 N-PORT
DXUV · Dimensional ETF Trust 0,01% 700 NS 30. April 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,00% 18.569 NS 31. Mai 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,00% 677 NS 31. Mai 2026 N-PORT
HDG · ProShares Trust 0,00% 17 NS 31. Mai 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 2.458 NS 30. April 2026 N-PORT
IWV · iShares Trust 0,00% 6.483 SH 8. August 2026 Täglich
DFAC · Dimensional ETF Trust 0,00% 17.507 NS 30. April 2026 N-PORT
ITOT · iShares Trust 0,00% 22.837 SH 8. August 2026 Täglich
DFAU · Dimensional ETF Trust 0,00% 3.011 NS 30. April 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 5.798 NS 30. April 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0,00% 10.304 NS 31. Mai 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,00% 555.846 SH 8. August 2026 Täglich
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 1.629 SH 8. August 2026 Täglich